Related Experiment Video
Updated: Jun 11, 2026

08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Hemorrhagic cholecystitis after anticoagulation therapy.
Yi-Ya Chen1, Chih-Hsun Yi, Chien-Lin Chen
1Department of Medicine and Pathology,Tzu Chi University, Hualien, Taiwan.
The American Journal of the Medical Sciences
|July 6, 2010
Summary
Hemorrhagic cholecystitis, a rare complication, can occur with anticoagulation. Early-stage cancer may increase bleeding risk in patients using heparin and aspirin for unstable angina.
Area of Science:
- Gastroenterology
- Hepatobiliary Surgery
- Oncology
Background:
- Hemorrhagic cholecystitis is a rare but serious complication of biliary tract disease.
- Nontraumatic causes of hemorrhagic cholecystitis are diverse.
- Anticoagulation therapy, such as heparin and aspirin, is commonly used for conditions like unstable angina.
Observation:
- An elderly patient developed hemorrhagic cholecystitis during treatment for unstable angina with heparin and aspirin.
- The patient underwent laparoscopic cholecystectomy for the condition.
Findings:
- Histopathology revealed adenocarcinoma in situ as the underlying cause.
- The combination of early-stage malignancy and anticoagulation significantly elevated bleeding risk.
Implications:
- This case highlights the critical interplay between occult malignancy and anticoagulation in precipitating hemorrhagic cholecystitis.
- Early detection of malignancy is crucial in patients presenting with unusual bleeding complications during anticoagulation therapy.
- Awareness of this association can guide clinical management and diagnostic workups in similar cases.
Related Concept Videos
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...